Dr. Andrew S. Camarata

Radiation Oncology
Gulf Region Radiation Oncology Centers
1545 Airport Blvd Ste 1000, 
Pensacola, FL 
Accepting New Patients
Gulf Region Radiation Oncology Centers
1545 Airport Blvd Ste 1000, 
Pensacola, FL 

Overview

Andrew Camarata is a Radiation Oncologist practicing medicine in Pensacola, Florida.

His clinical expertise encompasses Prostate Cancer, Lymphadenectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 10 clinical trials. Dr. Camarata is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Therapeutic Radiology in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

Gulf Region Radiation Oncology Centers
1545 Airport Blvd Ste 1000, Pensacola, FL 32504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Completed
Publish Date: July 09, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Radiation, Drug
Study Phase: Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Unknown
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 9 Less Clinical Trials

4 Total Publications

Quality of life results of addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy: NRG Oncology/RTOG 0534 SPPORT.
Quality of life results of addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy: NRG Oncology/RTOG 0534 SPPORT.
Journal: International journal of radiation oncology, biology, physics
Published: April 15, 2025
Similar Doctors
Expertise in
20
conditions
Dr. Veronica F. Carden
Radiation Oncology
Expertise in
20
conditions
Dr. Veronica F. Carden
Radiation Oncology
Referral may be required

Ascension Sacred Heart Radiation Oncology - Airport Medical Park

1545 Airport Blvd, Ste 1000, 
Pensacola, FL 
 (0.1 miles away)
850-416-6700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Veronica F. Carden, MD, is a radiation oncologist with Ascension Sacred Heart in Pensacola, FL. She provides personalized, compassionate care to adults. Dr. Carden has special medical interests in treating all types of cancers with radiation therapy, especially breast and lung cancers. She is skilled in stereotactic body radiation therapy (SBRT) which delivers precise radiation to small, well-defined tumors at a very high dose. Dr. Carden is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Carden is board certified in The American Board Of Radiology - Radiation Oncology. Dr. Carden is currently accepting new patients.

Expertise in
20
conditions
Dr. Coyt A. Rountree
Radiation Oncology
Expertise in
20
conditions
Dr. Coyt A. Rountree
Radiation Oncology
Referral may be required

Victor Hultstrand LLC

4724 N Davis Hwy, 
Pensacola, FL 
 (1.3 miles away)
850-696-4000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Coyt Rountree is a Radiation Oncologist practicing medicine in Pensacola, Florida. Dr. Rountree is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Carbuncle, Folliculitis, Boils, and Familial Prostate Cancer. Dr. Rountree is currently accepting new patients.

Expertise in
23
conditions
Dr. James F. Adams-Ii
Radiation Oncology
Expertise in
23
conditions
Dr. James F. Adams-Ii
Radiation Oncology
Referral may be required

Baptist Medical Group-Radiation Oncology

125 Baptist Way Ste 1C, 
Pensacola, FL 
 (1.5 miles away)
448-227-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Adams-Ii is a Radiation Oncologist practicing medicine in Pensacola, Florida. Dr. Adams-Ii is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Adams-Ii is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew S. Camarata

How do I make an appointment with Dr. Andrew S. Camarata?

You can book an appointment with Dr. Andrew S. Camarata by calling their office at 850-416-6700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew S. Camarata a top-rated expert for Lymphadenectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew S. Camarata is classified as an Experienced expert for Lymphadenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew S. Camarata specialize in?

While Dr. Andrew S. Camarata is a Radiation Oncology, they have specific expertise in Lymphadenectomy, Prostate Cancer, and Prostatectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Andrew S. Camarata participate in research or clinical trials?

Yes. Dr. Andrew S. Camarata has published 4 articles and abstracts on conditions like Lymphadenectomy. You can view a list of Dr. Andrew S. Camarata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew S. Camarata accept my insurance?

Dr. Andrew S. Camarata accepts most major insurance plans, including Florida Blue and Health Options. We recommend calling the office directly at 850-416-6700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Camarata's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile